$918 Million is the total value of Redmile Group, LLC's 54 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 59.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Buy | AMICUS THERAPEUTICS INC | $57,202,000 | +68.5% | 6,875,274 | +20.5% | 6.23% | +58.8% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $56,090,000 | +88.3% | 11,858,294 | +42.2% | 6.11% | +77.5% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $48,439,000 | +11.0% | 338,477 | +1.8% | 5.27% | +4.6% |
| CMRX | Buy | CHIMERIX INC | $46,588,000 | +50.5% | 1,157,184 | +3.2% | 5.07% | +41.8% |
| RAD | Buy | RITE AID CORP | $45,411,000 | +78.3% | 6,038,734 | +14.8% | 4.94% | +68.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $40,411,000 | +13.6% | 721,632 | -8.0% | 4.40% | +7.1% |
| RCPT | Sell | RECEPTOS INC | $38,313,000 | +40.2% | 312,736 | -28.9% | 4.17% | +32.2% |
| CELG | Sell | CELGENE CORP | $38,295,000 | +9.4% | 342,349 | -7.3% | 4.17% | +3.1% |
| AAVL | Sell | AVALANCHE BIOTECHNOLOGIES IN | $37,750,000 | +75.3% | 699,070 | -0.1% | 4.11% | +65.3% |
| GILD | New | GILEAD SCIENCES INC | $34,746,000 | – | 368,615 | +100.0% | 3.78% | – |
| SGEN | Buy | SEATTLE GENETICS INC | $31,615,000 | +563.1% | 983,966 | +667.3% | 3.44% | +524.7% |
| TRIV | Buy | TRIVASCULAR TECHNOLOGIES INC | $22,067,000 | -13.6% | 1,755,568 | +0.2% | 2.40% | -18.5% |
| ZSPH | Buy | ZS PHARMA INC | $21,812,000 | +17.3% | 524,702 | +10.7% | 2.38% | +10.6% |
| HWAY | Buy | HEALTHWAYS INC | $21,242,000 | +29.2% | 1,068,489 | +4.1% | 2.31% | +21.7% |
| FLDM | Buy | FLUIDIGM CORP DEL | $20,590,000 | +50.2% | 610,442 | +9.1% | 2.24% | +41.5% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $18,180,000 | – | 258,305 | +100.0% | 1.98% | – |
| MCK | Sell | MCKESSON CORP | $18,168,000 | -42.3% | 87,523 | -45.9% | 1.98% | -45.6% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $17,766,000 | +45.9% | 93,865 | +84.0% | 1.93% | +37.6% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $17,643,000 | +10.9% | 1,266,538 | -12.9% | 1.92% | +4.6% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $17,488,000 | +27.1% | 990,810 | -1.3% | 1.90% | +19.8% |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $17,269,000 | – | 860,809 | +100.0% | 1.88% | – |
| NUVA | Sell | NUVASIVE INC | $16,915,000 | -2.7% | 358,679 | -28.0% | 1.84% | -8.3% |
| HNT | Sell | HEALTH NET INC | $16,543,000 | +7.1% | 309,045 | -7.7% | 1.80% | +1.0% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $15,729,000 | +30.3% | 751,171 | -1.8% | 1.71% | +22.9% |
| INSM | Sell | INSMED INC | $15,661,000 | +10.0% | 1,012,371 | -7.2% | 1.70% | +3.7% |
| MODN | Buy | MODEL N INC | $15,523,000 | +8.0% | 1,461,678 | +0.3% | 1.69% | +1.8% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $15,050,000 | +16.3% | 135,270 | +9.3% | 1.64% | +9.7% |
| CIVI | Buy | CIVITAS SOLUTIONS INC | $14,978,000 | +54.9% | 879,485 | +42.0% | 1.63% | +46.0% |
| BIIB | New | BIOGEN IDEC INC | $14,635,000 | – | 43,113 | +100.0% | 1.59% | – |
| CSLT | Sell | CASTLIGHT HEALTH INCcl b | $14,593,000 | -33.0% | 1,247,268 | -25.9% | 1.59% | -36.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $14,587,000 | -10.4% | 1,070,995 | +0.4% | 1.59% | -15.6% |
| GMED | Sell | GLOBUS MED INCcl a | $14,541,000 | -23.5% | 611,731 | -36.7% | 1.58% | -27.9% |
| ARAY | Sell | ACCURAY INC | $11,593,000 | -3.4% | 1,535,475 | -7.1% | 1.26% | -8.9% |
| AKAOQ | Sell | ACHAOGEN INC | $9,578,000 | +38.8% | 733,953 | -4.7% | 1.04% | +30.9% |
| BLUE | New | BLUEBIRD BIO INC | $9,376,000 | – | 102,227 | +100.0% | 1.02% | – |
| NVRO | New | NEVRO CORP | $9,059,000 | – | 234,254 | +100.0% | 0.99% | – |
| CNXR | New | CONNECTURE INC | $8,496,000 | – | 943,000 | +100.0% | 0.92% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $7,069,000 | – | 264,266 | +100.0% | 0.77% | – |
| EHTH | Buy | EHEALTH INC | $6,602,000 | +53.9% | 264,942 | +49.0% | 0.72% | +45.0% |
| FLXN | Sell | FLEXION THERAPEUTICS INC | $6,363,000 | -25.2% | 315,144 | -32.4% | 0.69% | -29.5% |
| TKAI | Sell | TOKAI PHARMACEUTICALS INC | $3,171,000 | -49.5% | 215,139 | -48.1% | 0.34% | -52.4% |
| EBIO | New | ELEVEN BIOTHERAPEUTICS INC | $2,851,000 | – | 240,000 | +100.0% | 0.31% | – |
| New | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $1,869,000 | – | 2,000,000 | +100.0% | 0.20% | – | |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $1,866,000 | – | 237,977 | +100.0% | 0.20% | – |
| LOXO | Sell | LOXO ONCOLOGY INC | $1,618,000 | -77.2% | 137,681 | -74.5% | 0.18% | -78.5% |
| FWP | New | FORWARD PHARMA A/Ssponsored adr | $526,000 | – | 25,235 | +100.0% | 0.06% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $476,000 | – | 26,100 | +100.0% | 0.05% | – |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $418,000 | +1.2% | 6,500 | 0.0% | 0.05% | -4.2% | |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $401,000 | -97.0% | 4,887 | -97.8% | 0.04% | -97.2% |
| QQQ | New | POWERSHARES QQQ TRUSTunit ser 1 | $355,000 | – | 3,434 | +100.0% | 0.04% | – |
| IBB | Sell | ISHARES TRnasdq biotec etf | $303,000 | -33.0% | 1,000 | -39.5% | 0.03% | -36.5% |
| IHF | Sell | ISHARESus hlthcr pr etf | $296,000 | +2.4% | 2,500 | -7.4% | 0.03% | -3.0% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $257,000 | – | 1,390 | +100.0% | 0.03% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $64,000 | – | 25,000 | +100.0% | 0.01% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -18,400 | -100.0% | -0.05% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -2,212 | -100.0% | -0.06% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -125,973 | -100.0% | -0.32% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -49,200 | -100.0% | -0.35% | – |
| Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -100,000 | -100.0% | -0.52% | – | |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -303,571 | -100.0% | -0.66% | – |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -370,208 | -100.0% | -1.01% | – |
| CYBX | Exit | CYBERONICS INC | $0 | – | -172,900 | -100.0% | -1.02% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -172,772 | -100.0% | -1.03% | – |
| KYTH | Exit | KYTHERA BIOPHARMACEUTICALS I | $0 | – | -281,479 | -100.0% | -1.06% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -177,079 | -100.0% | -1.48% | – |
| CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -283,756 | -100.0% | -2.17% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -231,389 | -100.0% | -2.41% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -328,292 | -100.0% | -2.67% | – |
| B108PS | Exit | ACTAVIS PLC | $0 | – | -163,898 | -100.0% | -4.57% | – |
| Exit | ISHARES TRput | $0 | – | -450,000 | -100.0% | -5.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.